Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
(NASDAQ:TLX), NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) (“Telix”) American Depositary Shares (“ADS”) that a securities class action has been filed. The class period is between February 21, 2025 and August 28, 2025, inclusive. Investors have until […]